Evidence map›Paper›PMID 40839805›Full record

Trial reportJournal of nursing care quality

Safety and Cost Evaluation of Modified Medium-Length Catheters in Patients With Advanced Cancer: A Randomized Controlled Trial.

Yanfen Yu, Qin Zhou, Guanjun Ye, Jieqiong Yan, Yunjie Chen, Bona Wang

Abstract readRandomized Controlled Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Journal of nursing care quality. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yanfen YuIntravenous Therapy Nursing Department, Ningbo No. 2 Hospital, Ningbo, Zhejiang Province, China (Ms Yu, Ms Zhou, Ms Ye).
Qin ZhouIntravenous Therapy Nursing Department, Ningbo No. 2 Hospital, Ningbo, Zhejiang Province, China (Ms Yu, Ms Zhou, Ms Ye).
Guanjun YeIntravenous Therapy Nursing Department, Ningbo No. 2 Hospital, Ningbo, Zhejiang Province, China (Ms Yu, Ms Zhou, Ms Ye).
Jieqiong YanDay and General Ward, Ningbo No.2 Hospital, Ningbo, Zhejiang Province, China (Ms Yan).
Yunjie ChenGeneral Surgery Department II, Ningbo No. 2 Hospital, Ningbo, Zhejiang Province, China (Mr Chen).
Bona WangDepartment of Nephrology, Rheumatology, Immunology, and Endocrinology, The Affiliated Peoples Hospital of Ningbo University, Ningbo, Zhejiang Province, China (Ms Wang).ORCID 0009-0001-7942-0109

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDeep vein catheterization is common in patients with advanced cancer, but safety and cost comparisons between catheter types are limited. PURPOSE: To evaluate the safety and economic impact of a modified medium-length catheter versus a standard peripherally inserted central catheter (PICC) line in patients with advanced cancer.

methodsA prospective cohort study was conducted involving 160 patients with advanced cancer receiving palliative care between January 2022 and April 2024. Patients were randomized to a study group (modified medium-length catheter) or control group (PICC line). Venous complications, satisfaction, and costs were compared.

resultsThe study group had lower rates of venous thrombosis, bleeding, and catheter infection. Patient satisfaction and costs were also significantly better in the study group.

conclusionsThe modified medium-length catheter provides better safety, higher satisfaction, and reduced costs, making it a preferred option for patients with advanced cancer.

Indexed as

Catheterization, Central VenousCatheterization, PeripheralNeoplasmsPatient SafetyAgedFemaleHumansMaleMiddle AgedPalliative CarePatient SatisfactionProspective Studiesadvanced tumorclinical advantagemodified medium-length catheterPICCsafety evaluation

Identifiers

PMID40839805
PMCPMC12919650

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.